Paper Details

  1. Home
  2. Paper Details

Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.

Author: CastroJose G, Chin-BeckfordNafeesa

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Chronic diarrhea is a common concern in patients with HIV, even with antiretroviral therapy. This review discusses crofelemer, a newly approved medication for the symptomatic relief of non-infectious diarrhea in adults with HIV. Crofelemer has a novel mechanism of action and can improve quality of life and adherence to antiretroviral therapy.
Paper Details　
Original Abstract of the Article :
Chronic diarrhea remains a common condition that affects people infected with human immunodeficiency virus (HIV) despite the widespread use of potent antiretroviral therapy. It is important that providers control this condition, as the persistence of diarrhea affects the quality of life of patients ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1586/17512433.2015.1082424

データ提供：米国国立医学図書館（NLM）

Crofelemer: A New Hope for Diarrhea in HIV/AIDS Patients

Chronic diarrhea is a common and troublesome condition affecting individuals living with HIV/AIDS, despite the availability of potent antiretroviral therapy (ART). This condition significantly impacts quality of life and can even lead to decreased adherence to ART. This study examines the efficacy of a newly approved medication, crofelemer, for the symptomatic relief of non-infectious diarrhea in adult patients with HIV on ART. Crofelemer has a unique mechanism of action, working by protecting the intestinal lining from damage.

Crofelemer Offers Symptomatic Relief for Diarrhea in HIV/AIDS Patients

The study highlights the potential of crofelemer as a valuable tool for managing diarrhea in HIV/AIDS patients. Crofelemer's ability to provide symptomatic relief can improve quality of life and promote better adherence to ART.

Managing Diarrhea: A Vital Step Towards Improved Health

For patients with HIV/AIDS, effectively controlling diarrhea is crucial for overall well-being. This study emphasizes the importance of seeking appropriate medical advice and exploring available treatment options to manage diarrhea effectively.

Dr.Camel's Conclusion

Imagine a camel in a harsh desert, experiencing persistent bouts of diarrhea. Just as a camel needs a reliable source of water to survive, HIV/AIDS patients need effective solutions for managing diarrhea. Crofelemer, like a refreshing oasis, offers hope for symptomatic relief, improving quality of life and promoting better adherence to ART. This study is a significant step forward in the fight against this debilitating symptom and underscores the importance of innovative therapeutic approaches in managing HIV/AIDS.

Date :
  1. Date Completed 2016-06-01
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

26517110

DOI: Digital Object Identifier

10.1586/17512433.2015.1082424

Related Literature

Article Analysis
・Side Effects of crofelemer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.